Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Plos One|May 10, 2023
A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cellsTimothy K Soh, Susanne Pfefferle, Stephanie Wurr, et al.
The Journal of Infectious Diseases|November 5, 2015
Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa FeverLisa Oestereich, Toni Rieger, Anja Lüdtke, et al.
Plos Neglected Tropical Diseases|May 3, 2014
Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic feverLisa Oestereich, Toni Rieger, Melanie Neumann, et al.
Parasites & Vectors|July 15, 2018
Widespread arenavirus occurrence and seroprevalence in small mammals, NigeriaAyodeji Olayemi, Akinlabi Oyeyiola, Adeoba Obadare, et al.
Viruses|June 2, 2021
Validation of Inactivation Methods for ArenavirusesSilke Olschewski, Anke Thielebein, Chris Hoffmann, et al.
Plos Pathogens|May 19, 2016
Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa FeverLisa Oestereich, Anja Lüdtke, Paula Ruibal, et al.
Plos Pathogens|April 3, 2010
T cell-dependence of Lassa fever pathogenesisLukas Flatz, Toni Rieger, Doron Merkler, et al.
Journal of Virology|February 13, 2015
Ebola virus disease in mice with transplanted human hematopoietic stem cellsAnja Lüdtke, Lisa Oestereich, Paula Ruibal, et al.
Scientific Reports|May 9, 2026
Non-Mastomys rodents harbour ancient Lassa virus lineages within Benin and Nigeria's Guinea savanna beltAyodeji Olayemi, Adetunji Samuel Adesina, Akinlabi Oyeyiola, et al.
Pageof 4